L’EFSA publie toutes ses productions scientifiques, y compris ses avis scientifiques, dans l’EFSA Journal. L’Autorité édite également un éventail de publications connexes à l’appui des productions scientifiques. Voir aussi : Definitions of EFSA Scientific Outputs and Supporting Publications.
This statement supplements and updates the GMO Panel guidance document on allergenicity of genetically modified (GM) plants published in 2017. In that guidance document, the GMO Panel considered that additional investigations on in vitro protein digestibi ...
Following a request from the European Commission, the EFSA assessed the 2018 post‐market environmental monitoring (PMEM) report on the cultivation of Cry1Ab‐expressing maize event MON 810. Like previous years, there was partial compliance with refuge requ ...
In 2019, no lumpy skin disease (LSD) outbreaks were reported in South‐Eastern Europe, the mass vaccination regional campaign with homologous LSD vaccine continued for the fourth year with over 1.8 million bovines vaccinated in the region, preventing furth ...
No abstract available. doi: 10.2903/j.efsa.2020.e18021 Journal Number: EFSA Journal 2020;18(2):e18021 Adopted: 31 January 2020 Contact: gmo@efsa.europa.eu Author: Yann Devos, Elisabeth Waigmann, Nikoletta Papadopoulou, Tommaso Raffaello, Reinhilde Sc ...
At EFSA, animal dietary exposure estimates are undertaken by several Panels/Units to assess the risk of feed contaminants, pesticide residues, genetically modified feed and feed additives. Guidance documents describing methodologies for animal dietary exp ...
EFSA carries out the risk assessment of genetically modified organisms (GMOs) submitted under Regulation (EC) 1829/2003 and Regulation (EU) 503/2013. Dietary exposure is an essential element of the risk assessment on genetically modified (GM) foods. Dieta ...
Following a request from the European Commission, EFSA assessed the 2017 post‐market environmental monitoring (PMEM) report on the cultivation of Cry1Ab‐expressing maize event MON 810. Like previous years, partial compliance with refuge requirements is re ...
In 2018, no lumpy skin disease (LSD) outbreaks were reported in the Balkan region, after the decline reported in 2017 (385) compared to 2016 (7,483). This confirms the effectiveness of the vaccination campaign based on the LSD homologous vaccine strain wh ...
The duration of the vaccination campaign sufficient to eliminate lumpy skin disease (LSD) mainly depends on the vaccination effectiveness and coverage achieved. By using a spread epidemiological model, assuming a vaccination effectiveness of 65%, with 50% ...
The GMO Panel has previously assessed genetically modified (GM) carnation FLO‐40685‐2 and concluded that there is no scientific reason to consider that the import, distribution and retailing in the EU of carnation FLO‐40685‐2 cut flowers for ornamental us ...
EFSA Journal on Wiley